Susana Mejia-Mesa

Susana Mejia-Mesa

Auto-generated profile, based on publicly available information

Susana Mejia-Mesa

Dermatology Department, Clínica Aurora, Medellín, Colombia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2023 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
CACamilo Arias-Rodriguez
Camilo Arias-Rodriguez
AMAna Maria Muñoz-Monsalve
Ana Maria Muñoz-Monsalve
DCDiana Cuesta
Diana Cuesta
SMSusana Mejia-Mesa
Susana Mejia-Mesa
MAMaria Soledad Aluma-Tenorio
Maria Soledad Aluma-Tenorio
Basal cell carcinoma (BCC) dermoscopy is key to lower the biopsy threshold of suspicious lesions. There is a scarcity of published data on the dermoscopy of very small BCC (≤3mm) and its differences from larger BCCs. To describe and compare dermoscopic features of BCCs measuring ≤3mm, with those from 3 to 10mm. An analytical cross-sectional study, included biopsy-proven BCCs that had dermoscopic photographic images, between January 2017 and December 2022 in a Skin Cancer Center in Medellín, Colombia. Demographic, clinic-pathological and dermoscopic features were compared between very small BCCs (vsBCCs) and a reference group. A total of 326 BCCs in 196 patients were included, of whom 60% were male. The most common Fitzpatrick phototype was III. vsBCCs accounted for 25% of the lesions (81/326). Face and neck were the most frequent locations (53%), especially in very small tumors. The nodular type was more common in very small tumors than in larger lesions, the superficial type was less frequent, and aggressive types were equally prevalent in both groups. On dermoscopy, very small tumors were statistically more likely to present pigmented structures than reference lesions, especially blue-gray dots (67% vs. 54%), vessels were less frequent, particularly short-fine telangiectasias (SFT) (52% vs. 66%), as were other structures such as shiny white structures (SWS), ulceration, micro-erosions, and scales. Latin-American sample, lacks information on dark phototypes CONCLUSIONS: Pigmented structures, especially blue-gray dots, were most common in vsBCCs when compared to larger lesions; SFT, SWS and other findings were less prevalent.

16 June 2025 in Dermatology and Therapy
Verified
Journal Article
Open access
PDF file
FBFernando Bulla
Fernando Bulla
SMSusana Mejía
Susana Mejía
SGSebastian Gil-Quiñones
Sebastian Gil-Quiñones
SCSara Cataño
Sara Cataño
SSSusana Sierra
Susana Sierra
Introduction Actinic keratoses (AK) are premalignant skin lesions that occur in chronically photo-exposed body areas. Topical sunscreens prevent but do not reverse ultraviolet radiation (UVR)-induced damage to deoxyribonucleic acid (DNA). Eryfotona is a sunscreen product that combines high solar protection factors with light-driven DNA repair enzymes known as photolyases. This photolyase-based medical device has been shown to reduce the absolute number of AK; however, a more comprehensive assessment of AK lesions is ideal for determining its actual effect in everyday practice. The purpose of the study is to evaluate the photoprotective effect of Eryfotona sunscreen on individual AK lesions, assessing changes in their clinical and dermoscopic presentation in a real-life clinical setting and the impact on the health-related quality of life. Methods This was an observational, prospective, real-life study of adult patients with skin phototypes III or IV and actinic keratosis (AK) lesions on the face and scalp. Patients were treated with sunscreen containing photolyase twice daily for 6 months, with follow-up visits at 3 and 6 months. The clinical evaluation included the actinic keratosis and severity index (AKASI), the absolute number and individual dimensions of AK lesions, and the Olsen clinical classification scheme. The dermoscopic evaluation included the Zalaudek classification and assessment of lesion pigmentation. The AK Quality of Life (AKQoL) questionnaire was administered to patients during each follow-up. A repeated measures analysis of variance was performed to compare quantitative outcomes, and Fisher’s exact tests were used for categorical variables. Results A total of 45 patients with 205 AK lesions were included; 25 patients completed both follow-ups. Clinically, there was a significant improvement from an AKASI score of 2.55 at baseline to 1.90 at 6 months (p = 0.000), and a significant difference was also observed in the dimensions of individual AK lesions and the Olsen classification between the three evaluation times (p = 0.000). Dermoscopic assessment, as classified by the Zalaudek classification, showed significant improvement throughout the three evaluations (p = 0.000). In total, 53 lesions disappeared, corresponding to 26.36% of the lesions. Conclusions Eryfotona provided effective and safe photoprotection and treatment of actinic keratosis on the face and scalp in patients with phototypes III and IV in the real-life clinical setting, showing promising effects on higher-grade lesions.

1 November 2023 in Anais Brasileiros de Dermatologia (Versão em Português)
Verified
Journal Article
Open access
CACamilo Arias‐Rodriguez
Camilo Arias‐Rodriguez
AMAna Maria Muñoz‐Monsalve
Ana Maria Muñoz‐Monsalve
DCDiana Cuesta
Diana Cuesta
SMSusana Mejia‐Mesa
Susana Mejia‐Mesa
MAMaria Soledad Aluma‐Tenorio
Maria Soledad Aluma‐Tenorio